DOYLE THOMAS JAMES (SVP, Finance & Accounting) sold 3.4% of their position (4.54K shares) of KURA ONCOLOGY, INC. on the open market
Open‑market sale worth $50.7K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 11/14/2025ACC: 0001193125-25-283562
Officer· SVP, Finance & Accounting
Since Feb 2022
+20.43K
Net shares
Net buyer
$50.7K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
24.97K acquired · 4.54K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+24.97K
Price / share
—
Trade value
—
% of position
22.7%
11/13/2025
109.83K→134.80K
Common Stock
Direct
Shares
−4.54K
Price / share
$11.18
Trade value
$50.73K
% of position
3.4%
11/14/2025
134.80K→130.26K
Total
Net shares
+20.43K
Net value
-$50.73K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/13/2025 | A · Award | +24.97K | — | — | 22.7% | 109.83K | 134.80K |
| Common Stock Direct | 11/14/2025 | S · Sale | −4.54K | $11.18 | $50.73K | 3.4% | 134.80K | 130.26K |
| Total | +20.43K | -$50.73K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned500.00
Total
500.00 indirect500.00
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 500.00 | Indirect |
| Total | 500.00 | 500.00 indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported